论文部分内容阅读
2006年,中国制药行业经历了来自国内的政策和行业环境的变动,制药企业在采取措施积极适应各项变化的同时,透支了本应用于提高经营业绩的精力,使得近年保持2位数高速发展态势的医药行业在2006年骤然降温。2006年,我国医药生产企业实现销售收入5200亿元,同比增长17.53%,与2005年增幅相比下降了8个百分点;药品生产企业利润超过400亿元,同比增长11.01%,与2005年23%的增幅相比下降了12个百分点。
In 2006, the pharmaceutical industry in China experienced changes from domestic policies and industry environment. While taking measures to actively adapt to the changes, pharmaceutical companies overdraft their energies, which have been applied to improve business performance, resulting in the rapid development of 2-digit figures in recent years The trend of the pharmaceutical industry in 2006 suddenly cooling. In 2006, China’s pharmaceutical manufacturing enterprises realized sales revenue of 520 billion yuan, an increase of 17.53% over the same period of last year, a decrease of 8 percentage points from the growth in 2005; pharmaceutical manufacturers’ profits surpassed 40 billion yuan, up 11.01% from the previous year, A 12% drop from the increase in the previous year.